DAIC

APRIL 30, 2024

Image courtesy of Hideki Kobayashi from Shinshu University milla1cf Tue, 04/30/2024 - 12:53 April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. The highly positive outcomes observed in primate models highlight the potential of this strategy.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

Cardiology Update

JANUARY 22, 2024

Long-term outcomes were assessed at the eight highest-enrolling sites. The primary outcome was death from any cause, and the secondary outcome included a composite of death, heart transplantation, or ventricular assist device implantation. Secondary outcomes were experienced by 77.7% to 0.92; P=0.002).

Heart Failure 115

Heart Failure Defibrillator Heart Transplant Transplant 115

Stroke Journal

FEBRUARY 1, 2024

Introduction:Intraparenchymal stem cell transplantation shows therapeutic promise for chronic ischemic stroke patients. Visium identified specific gene clusters for the stroke injury, transplant/needle-track, stem cell graft, and the cortical ‘FLAIR’ region. Stroke, Volume 55, Issue Suppl_1 , Page ATP286-ATP286, February 1, 2024.

Transplant 40

Transplant Stroke Strokes Research 40

European Journal of Heart Failure

NOVEMBER 9, 2023

However, data on long-term outcome after upgrade to CRT are scarce. The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation.

Outcomes 40

Outcomes Heart Failure Heart Transplant Transplant 40

DAIC

MARCH 6, 2024

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. 3 ©2021 Millennium Research Group, Inc.

Pediatrics 105

Pediatrics Ultrasound Heart Transplant Echocardiogram 105

European Journal of Heart Failure

NOVEMBER 7, 2023

BNP, CMR-LVEF and SUVmax in FDG-PET: independent predictors of outcome in a contemporary cardiac sarcoidosis population remaining robust in subgroup subanalysis. Here, we describe baseline characteristics at presentation along with prognosis and predictors of outcome in a sizable and deeply phenotyped contemporary cohort of CS patients.

Sudden Cardiac Death 40

Sudden Cardiac Death Outcomes Heart Transplant Heart Failure 40

DAIC

DECEMBER 8, 2023

a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced the enrollment of the first patients in the company's IDE pivotal trial. These patients have very poor outcomes in terms of death and rehospitalization and therefore new therapy options are critically needed," stated Dr. Chehab.

Technology 113

Technology Heart Failure Heart Transplant Transplant 113

Society of Thoracic Surgeons - Research

MAY 5, 2023

About Annals of Thoracic Surgery Short Reports Annals of Thoracic Surgery Short Reports —the official fully open access companion journal to The Annals of Thoracic Surgery —provides a modern venue for authors to present their research in a digestible format, while also making it available immediately, permanently, and universally.

Article 52

Article Cardiothoracic Education Congenital 52

DAIC

MARCH 13, 2024

To my knowledge, no therapy has been proven to reduce mortality in these patients, and CardiAMP Heart Failure II has great potential to achieve this outcome by confirming our CardiAMP Heart Failure Trial results.” The study includes an eligibility requirement that patients demonstrate a pre-specified NT-proBNP level at baseline.

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

MIBHS

SEPTEMBER 30, 2024

The fear of the unknown, of potential surgeries, and of long-term outcomes can be paralyzing. This fear can be compounded by the uncertainty surrounding the condition, as each CHD case is unique, and outcomes can vary widely. The Children’s Heart Foundation : Focuses on funding research for CHDs and provides resources for families.

Congenital 52

Congenital Education Open-Heart Surgery Pediatrics 52

Open Heart

MAY 25, 2022

Methods The primary outcome was the prevalence and incidence of TE in the patients with LVNC. The secondary outcome was the TE and mortality and heart transplantation rates between paediatric and adult patients with LVNC. Studies that did not present original research, non-human studies, duplicated studies were excluded.

Heart Transplant 40

Heart Transplant Transplant Risk Factors Outcomes 40

European Journal of Heart Failure

OCTOBER 3, 2023

Characteristics of heart failure with improved ejection fraction (HFimpEF) patients and outcome comparison with heart failure with persistently reduced ejection fraction (pHFrEF). CV mortality is the composite endpoint for CV mortality + urgent transplant + left ventricular assist device implantation. Events per 1000 person-years. #

Heart Failure 40

Heart Failure Exercise Laboratory Transplant 40

Society of Thoracic Surgeons - Technology

JANUARY 19, 2022

With her fellowship, Dr. Fiedler plans to learn skills and administrative approaches that will help her expand the heart transplant program at UW-Madison, where she currently serves as associate director of heart transplantation and mechanical circulatory support. For more information, visit sts.org.

Cardiothoracic 52

Cardiothoracic Heart Transplant Allied Health Education 52

DAIC

FEBRUARY 13, 2024

THE TEXAS HEART INSTITUTE 2024 milla1cf Tue, 02/13/2024 - 17:56 February 13, 2024 — Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. The research, led by esteemed physician-scientist at The Texas Heart Institute ( THI ), Dr. James F.

Transplant 111

Transplant Pediatrics Heart Transplant Research 111

Cardiometabolic Health Congress

AUGUST 8, 2024

This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life.

Education 59

Education Diabetes Kidney Disease Cardiovascular Disease 59

Society of Thoracic Surgeons - Critical Care

MARCH 2, 2022

The researchers reported that 28 patients (93.3%) survived VV-ECMO. months since the patients were treated with VV-ECMO, survival was 86.7%, including one patient who underwent lung transplantation. A 6-minute walk test was performed in 16 patients (59.3%) with a median value of 350 meters, which the researchers called “encouraging.”

COVID-19 40

COVID-19 Cardiothoracic ICU Allied Health 40

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

Introduction Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in kidney transplant recipient (KTR). There is a dearth of standardized guidelines on optimal cardiovascular evaluation of transplant candidates. Posttransplant MACE has a negative effect on grafts and patient outcomes.

Transplant 64

Transplant Coronary Artery Disease Myocardial Infarction Cardiovascular Disease 64

Circulation: Heart Failure

FEBRUARY 20, 2024

Background:Black heart transplant patients are at higher risk of acute rejection (AR) and death than White patients. After transplant, Black patients had higher levels of dd-cfDNA, 0.09% (interquartile range, 0.001–0.30) compared with White patients, 0.05% (interquartile range, 0.001–0.23;P=0.003).

Heart Transplant 40

Heart Transplant Transplant Heart Failure Outcomes 40

DAIC

APRIL 6, 2024

While the trial did not meet its primary endpoint, it moves the field forward by offering signals that the benefits and risks of interatrial shunts may vary by heart failure type, according to researchers. Researchers tracked outcomes in each participant for at least one year and up to two years.

Heart Failure 81

Heart Failure Quality of Life Outcomes Preserved Ejection Fraction 81

Cardiology Update

APRIL 9, 2024

The percent change from baseline in fasting triglycerides (TG) at six months served as the primary outcome measure. The percent change from baseline in fasting TG at six months served as the primary outcome measure. Among patients with HFpEF, those who received the shunt experienced poor outcomes than those who did not.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

European Journal of Heart Failure

DECEMBER 13, 2023

Venn diagram of iron deficiency (ID) according to various definitions and associated outcomes. We evaluated three definitions of ID in patients referred for heart transplantation. Methods and results Consecutive patients assessed for heart transplantation at a single UK centre between January 2010 and May 2022 were included.

Heart Failure 40

Heart Failure Heart Transplant Transplant Tricuspid 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

DAIC

APRIL 6, 2024

While the trial did not meet its primary endpoint, it moves the field forward by offering signals that the benefits and risks of interatrial shunts may vary by heart failure type, according to researchers. Researchers tracked outcomes in each participant for at least one year and up to two years.

Heart Failure 98

Heart Failure Quality of Life Preserved Ejection Fraction Hospital 98

Stroke Journal

FEBRUARY 1, 2024

CPB is utilized for heart and lung transplants, aorta repairs, valve surgeries, mass resections, and coronary artery bypass grafting (CABG) which alone accounts for 400k patients per year. Outcomes included number and distribution of CMBs, presence of superficial siderosis, FAZEKAS, and CPB duration.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Transplant Patient Care Research 40